News - Brazil

Filter

Current filters:

Brazil

Popular Filters

1 to 25 of 38 results

Brazil’s Bionovis, BNDES and Fiocruz sign an investment agreement

Brazil’s Bionovis, BNDES and Fiocruz sign an investment agreement

07-07-2014

This month, the government of Brazil’s State of Rio de Janeiro, the Brazilian Development Bank (BNDES),…

BionovisBiosimilarsBiotechnologyBrazilFinancialFiocruzProductionResearch

Brazil’s ANVISA opens public consultation on bioavailability/bioequivalence of medicines

Brazil’s ANVISA opens public consultation on bioavailability/bioequivalence of medicines

04-07-2014

The Brazilian National Health Surveillance Agency, ANVISA, has initiated a public consultation to review…

BrazilPharmaceuticalRegulation

BioAlliance Pharma signs deal with EMS for Sitavig in Brazil

BioAlliance Pharma signs deal with EMS for Sitavig in Brazil

26-06-2014

French oncology specialist BioAlliance Pharma SA has announced a license agreement for Sitavig (acyclovir…

Antibiotics and Infectious diseasesBioAlliance PharmaBrazilLicensingPharmaceuticalSitavig

Brazil’s pharma demands tax exemptions and equality for medical products produced in Brazil

Brazil’s pharma demands tax exemptions and equality for medical products produced in Brazil

16-06-2014

Representatives from the Brazilian pharmaceutical industry last week defended the reduction of taxes…

BrazilFinancialHealthcarePharmaceuticalProduction

Targeted therapies must show cost effectiveness to compete with biosimilars in Brazil and Mexico

Targeted therapies must show cost effectiveness to compete with biosimilars in Brazil and Mexico

10-06-2014

Certain targeted therapies enjoy extensive but incomplete coverage in Brazil and Mexico through complex…

BiosimilarsBrazilJohnson & JohnsonMabTheraMexicoOncologyPharmaceuticalPricingRocheVelcade

ANVISA proposes new rules to expedite the approval of clinical research in Brazil

ANVISA proposes new rules to expedite the approval of clinical research in Brazil

05-06-2014

The Brazilian National Health Surveillance Agency (ANVISA) recently presented a proposal with new rules…

BrazilPharmaceuticalRegulation

BRIC nations identified as emerging leaders in global clinical trials landscape

BRIC nations identified as emerging leaders in global clinical trials landscape

28-05-2014

Despite challenges, increasing health care budgets and advancing markets in BRIC (Brazil, Russia, India…

BrazilChinaIndiaPharmaceuticalResearchRussia

Congressional hearing in Brazil will discuss the efficacy of generic medicines

26-05-2014

The Brazilian Commission for Consumer Protection will soon hold a hearing to discuss the effectiveness…

BrazilGenericsPoliticsRegulation

Fresenius Kabi expands IV drug business in Latin America with buy of Novafarma

Fresenius Kabi expands IV drug business in Latin America with buy of Novafarma

13-05-2014

Germany-based Fresenius Kabi has entered into an agreement to acquire the privately held Brazilian pharmaceutical…

BrazilFresenius KabiGenericsMergers & AcquisitionsNovafarma Industria Farmaceutica

Lilly to appeal $450 million fine in Brazil labor case

Lilly to appeal $450 million fine in Brazil labor case

10-05-2014

US drug major Eli Lilly revealed on Friday that the 2nd Circuit of the Labor Court of Paulinia in the…

BrazilEli LillyLegalPharmaceuticalProduction

Brazil predicts 3.9 billion real in law suits against the Union for the right to access to medicines

28-04-2014

Health authorities from all government levels have been charged with law suits filed by consumers of…

BrazilHealthcareLegalPharmaceuticalSouth America

Joint initiative aims to expedite clinical research in Brazil

Joint initiative aims to expedite clinical research in Brazil

14-04-2014

Representatives from universities, scientific research institutions and the pharmaceutical industry created…

BrazilCentral EuropeHealthNational Health Surveillance AgencyPharmaceuticalPharmaceutical industryPharmacologyPoliticsResearch

Brazil’s CMED approves price adjustment of medicines to 3.35%

04-04-2014

Brazil's National Health Surveillance Agency ANVISA’s office of pharmaceutical drug market regulation…

BrazilPharmaceuticalPricingSouth America

Study produces map of pharma industry and API production in Brazil

Study produces map of pharma industry and API production in Brazil

28-03-2014

Brazil is failing to produce the number of active pharmaceutical ingredients in order to produce the…

BrazilGenericsMarkets & MarketingProductionSouth America

New HIV/AIDS drug will be offered through Brazil’s SUS

New HIV/AIDS drug will be offered through Brazil’s SUS

27-03-2014

A medicine that combines tenofovir (Gilead’s Viread) and lamivudine (GlaxoSmithKline’s Combivir)…

Anti-viralsBlanver FarmoquimicaBrazilGenericsLamivudineProductionSouth AmericaTenofovir Disoproxil Fumarate

Brazil Senate discusses pathways for advancement of clinical research

Brazil Senate discusses pathways for advancement of clinical research

20-03-2014

The Brazilian Senate's Social Affairs Committee (CAS) held a hearing on March 18 to debate the progress…

BrazilPharmaceuticalRegulationResearch

Eli Lilly to expand manufacturing plants in Brazil’s growing pharma market

Eli Lilly to expand manufacturing plants in Brazil’s growing pharma market

03-03-2014

US pharma major Eli Lilly’s subsidiary in Brazil will invest 15 million real ($6.4 million) over the…

BrazilEli LillyPharmaceuticalPricingProductionSouth America

Brazil’s Congress will establish committee to evaluate tax exemption on medicines

Brazil’s Congress will establish committee to evaluate tax exemption on medicines

21-02-2014

Brazil’s Congress is considering a proposal on tax exemption on medicines and the house speaker Henrique…

BrazilPharmaceuticalPolitics

Increasing investment in Latin American pharma market

Increasing investment in Latin American pharma market

12-02-2014

Around $12.7 billion has been invested in Latin America’s pharmaceutical market through mergers and…

ArgentinaBrazilChileEcuadorFinancialMergers & AcquisitionsPharmaceuticalSouth America

1 to 25 of 38 results

Back to top